Vital Therapies Stock Price (NASDAQ:VTL)

Add to My Stocks
$3.85 $0.15 (3.75%) VTL stock closing price Mar 24, 2017 (Closing)
Prev Close* : $4.00
Market Cap:
$128.58M
Day Low: $3.7
52 Week Low: $3.70
Open: $4
Volume: 178875
Day High: $4
52 Week High: $9.71
Dividend:
N/A

Latest Stock Market News

Latest Articles

Vital Therapies News - From Partners

VTL Stockcharts

View VTL PE ratio, PS ratio stocks charts and compare with peers.
VTL Chart
Note: Compare Vital Therapies stock price history with the index and industry peers.

VTL Industry Peers

Company Price Change (%)
Bionomics Ltd (BNOEF)0.270 (0%)
Asterias Biotherapeutics (AST)3.250 (0%)
Cumberland Pharma (CPIX)6.390.01 (0.16%)
Chembio Diagnostics (CEMI)5.50.1 (1.85%)
Corgenix Medical (CONX)0.260.01 (3.7%)
Akers Biosciences (AKER)1.40.1 (7.69%)
Erba Diagnostics (ERBA)0.30 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Enzo Biochem (ENZ)8.430.52 (6.57%)
Peregrine Pharma (PPHM)0.7060.03 (4.44%)
Ophthotech (OPHT)3.530.15 (4.44%)
Kindred Biosciences (KIN)7.20.3 (4.35%)
Fortress Biotech (FBIO)3.60.14 (4.05%)
Immunomedics (IMMU)6.880.25 (3.77%)
Compugen (CGEN)4.350.15 (3.57%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)1.750.18 (9.35%)
Vital Therapies (VTL)3.850.15 (3.75%)
MannKind (MNKD)1.890.06 (3.08%)
PDL BioPharma (PDLI)1.980.05 (2.46%)
Sangamo BioSciences (SGMO)4.10.1 (2.38%)
Sorrento Therapeutics (SRNE)4.10.1 (2.38%)
Ultragenyx Pharma (RARE)70.321.67 (2.32%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017

Vital Therapies Inc Stock News - Partner Headlines

Vital Therapies Financial Statements

income statement2015201420132012
Net Sales Or Revenues----
Net Income-52.02M-47.66M-32.71M-6.7M
Total Operating Expense52.11M50.33M31.39M9.57M
view Vital Therapies Inc income statement
balance sheet2015201420132012
Total Assets89.08M108.08M46.58M-
Total Liabilities6.75M10.51M7.76M-
Shareholders Equity82.32M97.56M38.81M-
view Vital Therapies Inc balance sheet
cash flow statement2015201420132012
Net Increase (Decrease) In Assets Liabilities-3.28M5.82M1.03M-
Net Cash From (Used By) Operating Activities-49.95M-40.82M-28.64M-
Increase (Decrease) In Prop Plant And Equipment-2.34M-1.4M-1.48M-
view Vital Therapies Inc cashflow statement

Vital Therapies Stock Message Board

An investor needs to spend 3.85 to buy VTL stock, as the closing Vital Therapies stock price is 3.85. The total market value as denoted by 128.58M for Vital Therapies, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Vital Therapies stock analysis.

The terms stocks and shares mean the same thing. For Ex: Vital Therapies stock price and Vital Therapies share price mean the same thing. 178875 shares were traded with a closing stock price of 3.85 as of 24 Mar, 2017, as can be seen from Vital Therapies stock quote. One can view Vital Therapies stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Vital Therapies stock price history, gives the entire historical data for VTL stock.